{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:28:58Z","timestamp":1765294138620},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2005,5,3]],"date-time":"2005-05-03T00:00:00Z","timestamp":1115078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,3]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Increased prevalence of C4 null alleles is a common feature of autoimmune diseases. We have shown previously that complement-dependent prevention of immune precipitation (PIP) is defective in patients with systemic lupus erythematosus (SLE), and correlated this defect with C4A*Q0 and low levels of the C4A isotype. To further clarify the role of C4A in the aetiology of SLE, we now extend our studies to other diseases which have been associated with C4A*Q0. The frequency of C4A*Q0 was increased in Icelandic patients with coeliac disease (0\u00b750; P &amp;lt; 0\u00b7001), Grave's disease (0\u00b730; P = 0\u00b7002) and insulin-dependent diabetes mellitus (0\u00b723; P = 0\u00b704) and in British patients with dermatitis herpetiformis (0\u00b742; P = 0\u00b7002) and this was reflected in low levels of C4A. In spite of this, PIP was normal in these patients, and in marked contrast to our previous observations on connective tissue diseases, PIP measurements in these patient groups correlated more strongly with levels of C4B (r = 0\u00b751, P = 0\u00b70000004) than C4A. Patients with increased levels of anti-C1q antibodies had significantly lower PIP than patients without such antibodies (P\u2003&amp;lt;\u20030\u00b701) and a negative association of PIP with anti-C1q antibodies was also reflected in an increased prevalence (P = 0\u00b7006) and levels (P = 0\u00b7006) of anti-C1q antibodies in patients with subnormal PIP, as well as a negative correlation between PIP and anti-C1q antibodies (r = \u2212\u20030\u00b725, P = 0\u00b702). These results show that the PIP defect cannot be explained by low levels of C4A alone and suggest that measurements of anti-C1q antibodies may be useful in future studies on the molecular cause of the PIP defect in autoimmune connective tissue disease.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2005.02794.x","type":"journal-article","created":{"date-parts":[[2005,5,23]],"date-time":"2005-05-23T15:50:08Z","timestamp":1116863408000},"page":"572-579","source":"Crossref","is-referenced-by-count":10,"title":["Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0"],"prefix":"10.1093","volume":"140","author":[{"given":"G J","family":"Arason","sequence":"first","affiliation":[{"name":"Department of Immunology, Institute of Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kolka","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute of Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A B","family":"Hreidarsson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Landspitali University Hospital, Reykjav\u00edk, Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Gudjonsson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Landspitali University Hospital, Reykjav\u00edk, Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P M","family":"Schneider","sequence":"additional","affiliation":[{"name":"Institute of Legal Medicine, University Clinic, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Fry","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, St Mary's Campus, Imperial College of Science, Technology and Medicine, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Arnason","sequence":"additional","affiliation":[{"name":"National Blood Bank, Reykjav\u00edk, Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,5,23]]},"reference":[{"key":"2022010818035515700_b1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM198608213150805","article-title":"The role of complement and its receptor in the elimination of immune complexes","volume":"315","author":"Schifferli","year":"1986","journal-title":"N Engl J Med"},{"key":"2022010818035515700_b2","first-page":"269","article-title":"Complement C4 protein and DNA typing methods","volume":"210","author":"Schneider","year":"2003","journal-title":"Methods Mol Biol"},{"key":"2022010818035515700_b3","first-page":"1350","article-title":"Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC","volume":"18","author":"Christiansen","year":"1991","journal-title":"J Rheumatol"},{"key":"2022010818035515700_b4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/ard.57.8.503","article-title":"A study of the association of HLA DR, DQ, and complement C4 alleles with systemic lupus erythematosus in Iceland","volume":"57","author":"Steinsson","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"2022010818035515700_b5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/rheumatology\/keh183","article-title":"Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation","volume":"43","author":"Arason","year":"2004","journal-title":"Rheumatology"},{"key":"2022010818035515700_b6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.1780360711","article-title":"A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis","volume":"36","author":"Briggs","year":"1993","journal-title":"Arthritis Rheum"},{"key":"2022010818035515700_b7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.61.3.257","article-title":"Deficiency of complement-dependent prevention of immune precipitation in systemic sclerosis","volume":"61","author":"Arason","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2022010818035515700_b8","first-page":"274","article-title":"Increased freqeuncy of C4B*Q0 alleles in patients with Henoch Sch\u00f6nlein purpura","volume-title":"Scand J Immunol","author":"Thors"},{"key":"2022010818035515700_b9","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/j.1460-2075.1984.tb02052.x","article-title":"A comparison of the properties of two classes, C4A and C4B, of the human complement component C4","volume":"3","author":"Law","year":"1984","journal-title":"EMBO J"},{"key":"2022010818035515700_b10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0161-5890(88)90117-4","article-title":"The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulins","volume":"25","author":"Kishore","year":"1988","journal-title":"Mol Immunol"},{"key":"2022010818035515700_b11","first-page":"473","article-title":"Difference in the biological properties of the two forms of the fourth component of human complement (C4)","volume":"63","author":"Schifferli","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"2022010818035515700_b12","first-page":"149","article-title":"Deficiency of the effector mechanisms of the immune response and autoimmunity","volume":"129","author":"Lachmann","year":"1987","journal-title":"Ciba Found Symp"},{"key":"2022010818035515700_b13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1749-6632.1997.tb52069.x","article-title":"Complement deficiency and autoimmunity","volume":"815","author":"Walport","year":"1997","journal-title":"Ann NY Acad Sci"},{"key":"2022010818035515700_b14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00008480-199810060-00011","article-title":"Complement deficiency and autoimmunity","volume":"10","author":"Sullivan","year":"1998","journal-title":"Curr Opin Pediatr"},{"key":"2022010818035515700_b15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02099020","article-title":"Lupus diseases associated with hereditary and acquired deficiencies of complement","volume":"9","author":"Agnello","year":"1986","journal-title":"Springer Sem Immunopathol"},{"key":"2022010818035515700_b16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/08959374960100010801","article-title":"Pathophysiology of antinuclear antibodies in systemic lupus erythematosus and related diseases","volume":"10","author":"Tan","year":"1996","journal-title":"Adv Dent Res"},{"key":"2022010818035515700_b17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/096120339700600213","article-title":"Ultraviolet light-induced keratinocyte apoptosis. a potential mechanism for the induction of skin lesions and autoantibody production in LE","volume":"6","author":"Casciola-Rosen","year":"1997","journal-title":"Lupus"},{"key":"2022010818035515700_b18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0140-6736(84)92905-2","article-title":"Drugs that induce systemic lupus erythematosus inhibit complement component C4","volume":"2","author":"Sim","year":"1984","journal-title":"Lancet"},{"key":"2022010818035515700_b19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-5793(85)80631-1","article-title":"Hydralazine binds covalently to complement component C4. Different reactivity of C4A and C4B gene products","volume":"184","author":"Sim","year":"1985","journal-title":"FEBS Lett"},{"key":"2022010818035515700_b20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/bj2590415","article-title":"Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent","volume":"259","author":"Sim","year":"1989","journal-title":"Biochem J"},{"key":"2022010818035515700_b21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1042\/bj2510323","article-title":"Metabolites of procainamide and practolol inhibit complement components C3 and C4","volume":"251","author":"Sim","year":"1988","journal-title":"Biochem J"},{"key":"2022010818035515700_b22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0171-2985(84)80012-1","article-title":"Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls","volume":"166","author":"Bertrams","year":"1984","journal-title":"Immunobiology"},{"key":"2022010818035515700_b23","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diab.34.5.504","article-title":"Further definition of high-risk haplotypes in insulin-dependent diabetes","volume":"34","author":"Rich","year":"1985","journal-title":"Diabetes"},{"key":"2022010818035515700_b24","first-page":"143","article-title":"Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves\u2019 disease and Hashimoto's thyroiditis","volume":"3","author":"Skanes","year":"1986","journal-title":"Mol Biol Med"},{"key":"2022010818035515700_b25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00005792-198703000-00005","article-title":"Serositis with autoimmune endocrinopathy: clinical and immunogenetic features","volume":"66","author":"Tucker","year":"1987","journal-title":"Medicine (Baltimore)"},{"key":"2022010818035515700_b26","first-page":"183","article-title":"C4 and Bf phenotypes in black and Caucasian patients with childhood onset insulin dependent diabetes mellitus","volume":"30","author":"Wang","year":"1989","journal-title":"J Clin Lab Immunol"},{"key":"2022010818035515700_b27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1677\/jme.0.0030145","article-title":"C4A gene deletion: association with Graves\u2019 disease","volume":"3","author":"Ratanachaiyavong","year":"1989","journal-title":"J Mol Endocrinol"},{"key":"2022010818035515700_b28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0198-8859(93)90112-E","article-title":"MHC-extended haplotypes in families of patients with Graves\u2019 disease","volume":"36","author":"Ratanachaiyavong","year":"1993","journal-title":"Hum Immunol"},{"key":"2022010818035515700_b29","first-page":"643","article-title":"Expression and function of multiple regulators of complement activation in autoimmune thyroid disease","volume":"81","author":"Tandon","year":"1994","journal-title":"Immunology"},{"key":"2022010818035515700_b30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/diacare.19.1.53","article-title":"Polymorphism of complement C4 and susceptibility to IDDM and microvascular complications","volume":"19","author":"Lhotta","year":"1996","journal-title":"Diabetes Care"},{"key":"2022010818035515700_b31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ajmg.1320450319","article-title":"Extended major histocompatibility complex haplotypes in celiac patients in the west of Ireland","volume":"45","author":"Mannion","year":"1993","journal-title":"Am J Med Genet"},{"key":"2022010818035515700_b32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI112791","article-title":"Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy","volume":"79","author":"Alper","year":"1987","journal-title":"J Clin Invest"},{"key":"2022010818035515700_b33","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.178.6.2067","article-title":"Major histocompatibility complex susceptibility genes for dermatitis herpetiformis compared with those for gluten-sensitive enteropathy","volume":"178","author":"Ahmed","year":"1993","journal-title":"J Exp Med"},{"key":"2022010818035515700_b34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1744-313X.1990.tb00872.x","article-title":"HLA in juvenile dermatitis herpetiformis: clinical heterogeneity correlated with DNA and serological polymorphism","volume":"17","author":"Amoroso","year":"1990","journal-title":"J Immunogenet"},{"key":"2022010818035515700_b35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jdermsci.2003.11.004","article-title":"Dermatitis herpetiformis: close to unravelling a disease","volume":"34","author":"Karpati","year":"2004","journal-title":"J Dermatol Sci"},{"key":"2022010818035515700_b36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"2022010818035515700_b37","volume-title":"Werner and Ingbars The thyroid: a fundamental and clinical text","author":"Braverman","year":"1996","edition":"7th edn"},{"key":"2022010818035515700_b38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-1759(98)00199-9","article-title":"Enzyme immunoassays for measuring complement-dependent prevention of immune precipitation (PIP) and solubilization of preformed antigen\u2013antibody complexes (SOL)","volume":"223","author":"Arason","year":"1999","journal-title":"J Immunol Meth"},{"key":"2022010818035515700_b39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-3083.1985.tb01851.x","article-title":"Quantification of the C3d split products of human complement by a sensitive enzyme-linked immunosorbent assay","volume":"21","author":"Mollnes","year":"1985","journal-title":"Scand J Immunol"},{"key":"2022010818035515700_b40","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.1780331107","article-title":"IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis","volume":"33","author":"Siegert","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2022010818035515700_b41","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/ndt\/12.11.2263","article-title":"Occurrence of anti-C1q antibodies in IgA nephropathy","volume":"12","author":"Gunnarsson","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"2022010818035515700_b42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/jaut.1997.0147","article-title":"Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA","volume":"10","author":"Ronnelid","year":"1997","journal-title":"J Autoimmun"},{"key":"2022010818035515700_b43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/rheumatology\/36.1.32","article-title":"Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus","volume":"36","author":"Gunnarsson","year":"1997","journal-title":"Br J Rheumatol"},{"key":"2022010818035515700_b44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-3083.1994.tb03457.x","article-title":"Short-term kinetics of the humoral anti-C1q response in SLE using the ELISPOT method: fast decline in production in response to steroids","volume":"40","author":"Ronnelid","year":"1994","journal-title":"Scand J Immunol"},{"key":"2022010818035515700_b45","first-page":"117","article-title":"Quantitation of the human component C4: definition of C4, Q0 alleles and C4A duplications","volume-title":"Vox Sang","author":"Rebmann","year":"1992"},{"key":"2022010818035515700_b46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/rheumatology\/32.10.870","article-title":"HLA-DQ, DR and complement C4 variants in systemic lupus erythematosus","volume":"32","author":"Davies","year":"1993","journal-title":"Br J Rheumatol"},{"key":"2022010818035515700_b47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1399-0039.1996.tb02525.x","article-title":"HLA-DR, DQ genotypes of celiac disease patients and healthy subjects from the West of Ireland","volume":"47","author":"Michalski","year":"1996","journal-title":"Tissue Antigens"},{"key":"2022010818035515700_b48","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1353\/pbm.2001.0045","article-title":"Why is celiac disease so common in Ireland?","volume":"44","author":"Cronin","year":"2001","journal-title":"Perspect Biol Med"},{"key":"2022010818035515700_b49","first-page":"60","article-title":"Coeliac disease in Galway, Ireland 1971\u201390","volume":"90","author":"Gumaa","year":"1997","journal-title":"Ir Med J"},{"key":"2022010818035515700_b50","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3476(05)83336-0","article-title":"Association of Henoch\u2013Sch\u00f6nlein purpura glomerulonephritis with C4B deficiency","volume":"117","author":"Ault","year":"1990","journal-title":"J Pediatr"},{"key":"2022010818035515700_b51","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1984.228","article-title":"Complement phenotypes in glomerulonephritis. Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch\u2013Sch\u00f6nlein purpura","volume":"26","author":"McLean","year":"1984","journal-title":"Kidney Int"},{"key":"2022010818035515700_b52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0090-1229(84)90011-4","article-title":"Characterization of C1q-binding IgG complexes in systemic lupus erythematosus","volume":"30","author":"Uwatoko","year":"1984","journal-title":"Clin Immunol Immunopathol"},{"key":"2022010818035515700_b53","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ki.1989.61","article-title":"Antibody to a cryptic, solid phase C1Q antigen in membranoproliferative nephritis","volume":"35","author":"Strife","year":"1989","journal-title":"Kidney Int"},{"key":"2022010818035515700_b54","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.1780331107","article-title":"IgA antibodies to the collagen-like region of C1q in rheumatoid vascolitis","volume":"33","author":"Siegert","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2022010818035515700_b55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00005792-199501000-00003","article-title":"Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients","volume":"74","author":"Wisnieski","year":"1995","journal-title":"Medicine (Baltimore)"},{"key":"2022010818035515700_b56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2249.1999.00867.x","article-title":"Autoantibodies against C1q: view on clinical relevance and pathogenic role","volume":"116","author":"Siegert","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2022010818035515700_b57","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2004.024943","article-title":"Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus","volume-title":"Ann Rheum Dis","author":"Marto","year":"2004"},{"key":"2022010818035515700_b58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/clin.1993.1066","article-title":"The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus","volume":"67","author":"Siegert","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"2022010818035515700_b59","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0272-6386(99)70402-6","article-title":"Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus?","volume":"34","author":"Trendelenburg","year":"1999","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2005.02794.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/140\/3\/572\/42081296\/j.1365-2249.2005.02794.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/140\/3\/572\/42081296\/j.1365-2249.2005.02794.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T18:05:43Z","timestamp":1641665143000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/140\/3\/572\/6440511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,3]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,5,23]]},"published-print":{"date-parts":[[2005,5,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02794.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,6]]},"published":{"date-parts":[[2005,5,3]]}}}